Promoting Clinical Trial Participation (BCT) is a patient-centered web service designed to increase public awareness and access to clinical trials. Launched in 2008, following a successful UCSF-NCI sponsored research pilot, its mission is to make patient consideration of trials the norm vs. the exception, both to ensure that every patient has access to the latest medical knowledge for breast cancer treatment as well as to advance breast cancer research.
BCT features online tools to help patients find trials personalized to their situation. These include:

  • BCT Match: Personalized matching to trials based on a user’s self-reported diagnostic and treatment history; users find trials for which they are most likely to be eligible.


  • BCT Browse: Provides links to groups of trials organized by: Category such as targeted therapy or immunotherapy; or Tumor Type such as newly diagnosed or metastatic disease


  • Metastatic Trial Search (MTS): Powered by BCT and in collaboration with five breast cancer advocacy groups, MTS is embedded on each organization's website. (Launched in October 2015 and funded by the Avon-Pfizer Metastatic Grant Program.)

Operating as a non-profit service, BCT lists over 600 studies for people with newly diagnosed breast cancer, metastatic disease, or post-treatment survivors. It includes innovative trials of targeted and immunotherapies as well as observational studies looking at quality of life, genetic mutations, and breast cancer survivorship, accompanied by easy-to-read trial summaries.


For more information, contact project leader Elly Cohen, PhD, (415) 476-0264 or